TTC17 and breast cancer: TTC17 knockdown in BC cells significantly increased the expression of RAP1A, RAP1-GTP, and CDC42 levels (Fig. 4f, g, Additional file 2: Fig. S7a), while overexpressing TTC17 produced the opposite phenomena (Fig. S7b).